Stocks
GlaxoSmithKline (GSK) CAPEX US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| CAPEX, £ | ? | 2 654 000 000 | 1 407 924 743 | 1 633 370 123 | 2 982 000 000 | 1 318 459 170 | 2 064 617 827 | ||
| Changes by years, y/y, % | +36% | -47% | +16% | +83% | -56% | -7.5% | |||
GlaxoSmithKline. CAPEX, £
GlaxoSmithKline. CAPEX, changes, %
GlaxoSmithKline. CAPEX, sum by quarters, £
GlaxoSmithKline (GSK) CAPEX US GAAP (quarter values) |
||||||||
| FY2025Q1 | FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | LTM ? | |||
| CAPEX, £ | ? | 448 000 000 | 633 000 000 | 428 372 729 | 560 245 098 | 443 000 000 | 2 064 617 827 | |
| Changes by years, y/y, % | +42% | +43% | -49% | -51% | -1% | |||
| Changes by quarters, q/q, % | -61% | +41% | -32% | +31% | -21% | |||
